Background/Objectives: Previous research investigating the impact of glucose ingestion and/or improvements in glucose regulation has found selective cognitive facilitation on episodic memory tasks in successful ageing and dementia. The present study aimed to extend this research to mild cognitive impairment (MCI). Subjects/Methods: In a repeated-measures design, 24 older adults with and 24 older adults without MCI performed a battery of memory and attention tasks after 25 g of glucose or a sweetness matched placebo. In addition, to assess the impact of individual differences in glucose regulation, blood glucose measurements were taken throughout the testing session. Results: Consistent with previous research, cognitive facilitation was observed for episodic memory tasks only in both successful ageing and MCI. Older adults with MCI had a similar glucose regulatory response as controls but their fasting levels were elevated. Notably, higher levels of blood glucose were associated with impaired memory performance in both the glucose and placebo conditions. Importantly, both blood glucose and memory performance indices were significant predictors of MCI status. Conclusions: The utility of glucose supplementation and the use of glucose regulation as a biological marker are discussed in relation to these data.
Introduction
An understanding of human memory across the lifespan, its strengths and weaknesses, and how an individual can minimize decline has important social and clinical implications for elderly individuals (White, 1998) . Episodic memory in particular is known to decline in ageing (see Zacks et al., 1999 for a review) and is a significant factor contributing to reduced quality of life in old age. Indeed, interventions aimed at improving memory function elsewhere have been successful in improving subjective well-being in ageing and dementia (Bellevillea et al., 2006) . Successful episodic remembering involves the retrieval of detailed item and contextual information associated with a previously experienced event. This type of memory is crucial to everyday functioning and if disrupted, as for instance in dementia, has serious consequences for behaviour (Schacter and Dodson, 2001) . However, poor memory function is not immutable and interventions utilizing everyday nutritional substances have proven to be beneficial. Here, we consider glucose ingestion and improvements in glucose regulation as possible sources of memory enhancement within an elderly population with and without mild cognitive impairment (MCI).
Glucose, a monosaccharide, 'yis the most abundant organic molecule available on the planet' (Davis and Fairbanks, 2002, p. 1) . The brain uses glucose almost exclusively as its basic fuel (Parker and Benton, 1995) and requires a relatively constant supply since storage capabilities are limited (Mark and Rose, 1981) . This fact is particularly relevant for individuals with diabetes where impaired glucose availability may lead to poor cognitive performance (see Biessels et al., 2002 for review) . Early investigations of the impact of increasing glucose availability on memory were conducted with rodents. For instance, Winocur and Gagnon (1998) investigated the effects of glucose on both younger and older rats in tests of spatial learning and memory. In general aged rats showed relatively poorer learning than younger rats in the sample; due to hippocampal dysfunction. Such age-related deficits were reduced with the introduction of glucose. Work on humans mirrors this early work on rodents with glucose facilitation (after a glucose-containing drink) largely found with memory tasks and arguable more consistent findings in an elderly population (for recent reviews see Messier, 2004; Riby, 2004; . The enhancement effect has also been seen in populations with disorders such as schizophrenia, Down's syndrome and Alzheimer's disease (AD) presumably because there is more room for improvement in these groups or glucose specifically impacts on brain regions impaired in these populations (see Sünram-Lea et al., 2002; for discussion of the hippocampus hypothesis). While glucose facilitation and glycaemic control has been investigated in successful ageing and dementia, individuals from the intermediate MCI stage have not been investigated.
Individuals with MCI have impairments on a variety of cognitive tasks. The commonest form described is amnestic, where memory disorder is the prominent finding (Gauthier and Rockwood, 2003; Ganguli et al., 2004) . Amnestic MCI is widely acknowledged as a precursor to AD, so mechanisms for detection and intervention at this stage are still widely sought after-especially as recent studies have demonstrated that MCI can also have subtle negative effects on complex everyday tasks or activities (Pernecky et al., 2006a, b) . The relationship between glucose concentration, glucose regulation and cognition is particularly relevant in less successful ageing where known glucose abnormalities exist. Indeed, diabetes alongside other dementia-related disease processes is thought to accelerate cognitive decline (for review see Messier, 2005) . A greater understanding of the complex relationship that exists between glucose abnormalities and cognitive function will provide the groundwork for the possible use of a glucose regulatory index to not only predict cognitive decline but also to predict progression from normal ageing to MCI or dementia. The current study therefore aims to extend previous research on the glucose facilitation effect to examine MCI, and to further investigate glucose regulation as a predictor of cognitive decline.
Methods
Participants Twenty-four patients with MCI were recruited through the Memory Clinic, Kingshill Research Centre, Swindon (mean age 73, s.d. 5.4 years) and twenty-four older adults (mean age 71, s.d. 5.6 years) were recruited as a control group from a participant pool held at the Department of Psychology, Glasgow Caledonian University. MCI was defined as subjective and objective memory loss (using the Hopkins Verbal Learning Test and the New York Paragraph Recall test; Kuslansky et al., 2004) in the absence of significant executive dysfunction, loss of complex activities of daily living (for example organizing work, managing finances and using public transport; Perneczky et al., 2006a, b) or the presence of depression, delirium or any other potentially conflicting condition. There were no differences between the groups in relation to years of education (mean of 12.5 and 12.6 years of education), body mass index (mean of 25.6 and 25.3) or National Adult Reading Test (mean of 36.0 and 37.4) for the MCI and control groups respectively. Mini-Mental State Exam performance differed between the MCI and the control groups (t(45) ¼ 2.8, Po0.01; mean of 27.7 and 29.1 for the MCI and control groups respectively). None of the participants were diabetic. To minimize the impact of other health factors on cognitive function and glycaemic response all participants were stabilized on any current medication over the testing period. In addition, taking cholinesterase inhibitors or benzodiazipines was exclusion criterion.
Design and treatment
A repeated-measures, counterbalanced, double-blind design was used with all participants receiving the experimental solution (25 g of glucose). Twenty-five grams of glucose has previously been identified as the optimal dose to produce facilitation in the elderly (see Parsons and Gold, 1992 for discussion of the inverted-U dose-response curve). Indeed, in a recent meta-analysis 25 g glucose load produced an effect size of d ¼ 0.79 compared to d ¼ 0.20 for over 25 g (Riby, 2004) . The control solution consisted of 37.5 mg saccharin. To control for sweetness reinforcement effects, the treatment drinks contained sugar-free whole-orange squash (glucose ¼ 30 ml, saccharin ¼ 45 ml) dissolved in 250 ml of water.
Blood glucose apparatus
Blood glucose measurement was taken using an automatic sensing and lancing device (MediSense UK Ltd). Pure powder glucose and saccharin were supplied by The Boots Company Plc, England.
Procedure
All participants attended two sessions between 0900 and 1600 hours separated by approximately 1 week (the second session was carried out at the same time of day), each lasting approximately 1 h. After fasting for 2 h participants received either the glucose or the saccharin drink (see Sünram-Lea et al., 2001 for discussion of appropriate fasting regimes and time of day effects). Testing commenced 10 min after ingestion. Each session followed an identical fixed order procedural timetable (Table 1) .
Picture recognition
All participants were shown 20 drawings over a 30 s time period. They were later shown 40 drawings (including the 20 target items) and asked to identify which of these they had previously seen. Their total score was calculated by deducting the number of false positives from the number of pictures correctly identified.
Story task
Each participant was read a short passage of five lines taken from the Rivermead memory assessment (Rivermead Behavioural Memory Test-Extended Version). They were asked to listen carefully and then immediately recall as much as they could. They were later asked to again recall as much of the passage as possible. Their responses were written down verbatim and they scored 1 point for each of the 21 'ideas' correctly recalled and 0.5 points for each of the 'ideas' partially recalled. Sustained attention to response task Our sustained attention task was a variation of the sustained attention to response task (SART) employed by Robertson et al. (1997) . During the computerized attention task participants were required to respond to frequent target stimuli ('X') and withhold a response to an infrequent nontarget stimuli ('Y') that were presented on the computer screen at regular intervals. There were two experimental blocks each containing randomly presented targets (n ¼ 208) and non-targets (n ¼ 52). A trial consisted of a fixation cross for 900 ms, stimulus (either X or Y) for 300 ms and finally a blank screen for 200 ms. The spacebar on a standard PC keyboard was used to make responses. Measurement of correct hits, reaction time of hits and false alarms were recorded.
Stress and arousal measurement Differences in arousal across glucose and saccharin conditions could account for patterns of glucose enhancement effects. Therefore, the Stress-Arousal Inventory (MacKay et al., 1978) was administered at four intervals throughout the experiment.
Results

Blood glucose measurements
To determine the effectiveness of the glucose manipulation, an initial analysis was conducted on the blood glucose data. A 2 (group: normal vs MCI) Â 2 (glucose vs saccharin) Â 4 (time of measurementÀbaseline, test two, test three and test four) analysis of variance (ANOVA) was conducted on the blood glucose measures. There were main effects of treatment (F(1,45) ¼ 93.0, mean square error (MSE) ¼ 4.25, Po0.001), group (F(1,45) ¼ 9.6, MSE ¼ 6.5, Po0.001) and time (F(3,135) ¼ 9.2, MSE ¼ 1.06, Po0.001). There was also a treatment Â time interaction (F(3,135) ¼ 40.9, MSE ¼ 1.2, Po0.001). These data indicated that blood glucose remained constant across time in the placebo condition, while increasing steadily post-drink until test point 3 (40 min post-drink) before falling towards baseline in the glucose condition. The group effect indicated higher overall glucose level throughout the testing session for the MCI group (Figure 1) . Indeed, baseline blood glucose level was a significant predictor of group membership (non-MCI vs MCI) with respectively 75 and 67% of individuals correctly classified for the MCI and successful ageing groups (logistic regression with baseline blood glucose measures entered as predictors; Nagelkerke R 2 ¼ 0.29; predicted probability cutoff 0.5).
Stress and arousal questionnaire
To determine the influence of stress a 2 (group: normal vs MCI) Â 2 (glucose vs saccharin) Â 4 (time of measurementÀbaseline, test two, test three and test four) ANOVA was conducted. There were main effects of time only (F(3,138) ¼ 7.25, MSE ¼ 10.1, Po0.001; means ¼ 3.1, 5.1, 4.7 and 4.5 for time points 1, 2, 3 and 4 respectively). The same analysis was repeated on the arousal component of the questionnaire. No significant main effects or interactions were observed. Significant and marginal effects shown in parenthesis.
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Blood glucose levels and performance
The relationship between glucose regulation and cognitive performance was investigated by performing a series of correlation analyses at time points 1 (baseline), 2 (25 min), 3 (40 min) and 4 (55 min). A summary of these analyses is provided in Table 3 . For episodic recall (immediate and delayed) poor performance was related to elevated blood glucose (5 of the 16 correlations reached significance, all P'so0.05; 5 of the 16 correlations approached significance, all P'so0.08).
Discussion
The main aims of the current study were to extend research on the glucose facilitation effect to MCI and to investigate glucose regulation as a predictor of cognitive decline. This is timely as the search for early predictive biomarkers and disease-modifying treatments of dementia continues. If changes in glucose regulation that can be demonstrated with relatively minimal invasiveness can be used to predict prognosis in people with early signs of memory loss, it may prove a valuable screening method. If the reason this works is also related to a potential treatment mechanism for cognitive decline (especially AD), this opens the possibility of a diagnostic test and/or method of measuring change with an intervention in very mild cases. In considering the glucose response, it was noted that the baseline level of blood glucose was higher in individuals with MCI. However, the response to glucose load in MCI was similar to non-MCI, but peaked at a higher level (Figure 1) . One possible interpretation of this data is that high blood glucose may prove to be another predictor of MCI status. Indeed, impaired fasting glucose and diabetes status have been considered risk factors for developing MCI and dementia elsewhere (Yaffe et al., 2004) . In relation to typical glucose concentrations of those with diabetes mellitus and associated disorders, MCI individuals approached the classification of impaired fasting (6.1-6.9 mmol l À1 ; Alberti and Zimmet, 1998) . It is not unreasonable to suggest that these individuals may progress to impaired glucose tolerance or diabetes status, both of which have been associated with more severe cognitive impairment. However, what should be noted is that in the present investigation fasting blood glucose was evaluated after a 2-h fast. Although recent research investigating the glucose facilitation effect has favoured the 2 h fasting approach (for example Sünram-Lea et al., 2001) further experimental work using the more traditional overnight fast is warranted. It is clear that an important concern for research is to disentangle the complex relationship that exists between glucoregulatory mechanisms, other dementia-related processes and cognition. Even with limited knowledge of how these factors interact, an elevated risk of both vascular dementia and AD exists for those with diabetes and associated disorders (Stewart and Liolitsa, 1999; Messier, 2005) .
The enhanced performance of the delayed story recall task (Table 2) resulting from glucose is consistent with the suggestion that the facilitation effect is domain specific. Episodic memory recall, known to decline in ageing, was found to be sensitive to glucose ingestion. This finding is consistent with the idea that the hippocampal functioning declines with age (Morrison and Hof, 2003) , the hippocampus is central to memory formation (Mayes and Roberts, 2001 ) and glucose has a selective impact in the hippocampus (Winocur, 1995) . However, whether MCI individuals can particularly benefit remains debatable since the glucose facilitation effect was not exaggerated in this group. Regardless, this study extends our understanding of glucose ingestion to encompass MCI. What should be noted is that the magnitude of the effect was small and perhaps additional glucose reserve may have promoted greater facilitation. Indeed, selected studies have found 50 g to be optimal rather than 25 g in an older population (Hall et al., 1989; Manning et al., 1990) . As expected, there was no significant effect on recognition memory (picture recognition) since the glucose action seems to be restricted to those tasks of sufficient difficulty and/or supported by the hippocampus (Kennedy and Scholey, 2000; . There was also no significant effect found on the performance of the SART, although response time was faster and the false alarm rate was higher in the MCI group. Previous research has linked rapid performance on the SART task to a lack of conscious control of behaviour (Robertson et al., 1997) and so it would be useful for future work to consider the SART as a possible tool for investigating the cognitive deficits associated with MCI.
While previous research has suggested caution in interpreting correlations between blood glucose data and cognitive performance (Sünram-Lea et al., 2002) , the data are able to give some idea of how glucose regulation is related to cognition. Studies such as that by Riby et al. (2004) have demonstrated that glucose regulation can predict episodic memory performance, both in glucose and control conditions. In the current study, relationships between poor glucose regulation (indexed by a rise and more prolonged fall back to baseline after glucose load) and poor episodic memory were found (Table 3 ). The data here suggest that a glucoregulatory measure could be a useful predictor of cognitive decline as indexed by episodic memory, this is in line with fasting data presented earlier. This suggests that as well as a useful predictive tool, interventions aimed at improving glucose regulation may improve memory performance. Lifestyle interventions (for example diet and exercise) may be particularly beneficial for this purpose, particularly since such a strategy has been suggested to be more effective than pharmacological interventions (Unwin et al., 2002) .
In conclusion, the current study has extended our understanding of the glucose facilitation effect by considering elderly individuals with and without MCI. Our data demonstrate glucose-dependent facilitation for delayed episodic memory in a population known to have deficits on these tasks. One noteworthy finding was that the ingestion of a glucose-containing drink did not exaggerate the facilitation effect for individuals with MCI. Since differences in fasting blood glucose were observed between MCI and normal elderly individuals, in future studies an adjustment in the dose may be warranted. Importantly, our data add to the general consensus that amnestic MCI is a very mild form of AD, at a stage that has not reached the clinical realm of dementia. It is at this stage that an assessment utilizing a glucoregulatory measure could be a valuable biomarker for dementia-related cognitive decline.
